Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 18, 2018 - Issue 4
Submit an article Journal homepage
275
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

GP2015 as a promising therapy for rheumatoid arthritis

John FittonLeeds Institute of Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK;NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UKView further author information
,
Alessandro GiolloDepartment of Medicine, Rheumatology Unit, University of Verona, 5 Verona, ItalyView further author information
&
Maya H. BuchLeeds Institute of Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK;NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UKCorrespondence[email protected]
View further author information
Pages 477-481 | Received 19 Jan 2018, Accepted 12 Mar 2018, Published online: 20 Mar 2018

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Aliki I. Venetsanopoulou, Paraskevi V. Voulgari & Alexandros A. Drosos. (2022) Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis. Expert Review of Clinical Immunology 18:5, pages 485-493.
Read now

Articles from other publishers (3)

Pan Tian, Jialing Xiong, Wanxia Wu, Shanshan Shi, Aizhen Chen, Kaihong Chen, Weihua Chen, Aiyu Wu & Ying Liao. (2023) Impact of the malnutrition on mortality in Rheumatoid arthritis patients: A cohort study from NHANES 1999–2014. Frontiers in Nutrition 9.
Crossref
Nuria Carballo, Carolina Pérez García, Santiago Grau, Jordi Monfort, Xavier Durán-Jordà, Daniel Echeverría-Esnal & Olivia Ferrández. (2022) Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study. Frontiers in Pharmacology 13.
Crossref
Zongfang Zhang, Jie Pang, Yanxia Li, Wenwen Yang, Xin Cui & Huaheng Xu. (2022) Folic Acid Modified Glucosamine/Methotrexate Polymer Targeted Therapy for Rheumatoid Arthritis. Journal of Nanomaterials 2022, pages 1-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.